Breaking News Instant updates and real-time market news.

FMS

Fresenius Medical

$32.21

-2.05 (-5.98%)

05:20
10/23/19
10/23
05:20
10/23/19
05:20

Fresenius Medical downgraded to Neutral from Buy at Redburn

Redburn analyst Ed Ridley-Day downgraded Fresenius Medical Care to Neutral from Buy.

  • 29

    Oct

FMS Fresenius Medical
$32.21

-2.05 (-5.98%)

10/26/18
UBSW
10/26/18
UPGRADE
UBSW
Buy
Fresenius Medical upgraded to Buy from Neutral at UBS
UBS analyst Ian Douglas-Pennant upgraded Fresenius Medical to Buy while lowering his price target for the shares to EUR 82 from EUR 86. The analyst says the Q3 pre-release selloff presents a buying opportunity.
11/20/18
RHCO
11/20/18
NO CHANGE
Target $46
RHCO
Buy
Fresenius Medical price target lowered to $46 from $62 at SunTrust
SunTrust analyst David MacDonald lowered his price target on Fresenius Medical to $46 to reflect its "soft" Q3 results with a lower implied valuation of 10-times forward EBITDA. The analyst believes that given the mixed fundamentals, the stock is a "show me" story, even though he keeps his Buy rating on Fresenius Medical longer term based on its "solid core volume trends, attractive overarching industry drivers, a diversified business model, and strong free cash generation".
02/21/19
RHCO
02/21/19
NO CHANGE
Target $48
RHCO
Buy
Fresenius Medical price target raised to $48 from $40 at SunTrust
SunTrust analyst David MacDonald raised his price target on Fresenius Medical to $48 and kept his Buy rating after its Q4 results yesterday, saying the quarter was "marked by solid organic trends, ongoing efficiency gains and strong cash flow." The analyst anticipates the company's 2019 to be a year of investment but sees the incremental spending driving more optimization and positioning Fresenius Medical for "attractive growth opportunities". MacDonald adds that he is positive on the company's pending acquisition of NxStage Medical (NXTM) given the market shift "towards the home".
06/20/19
LEHM
06/20/19
UPGRADE
LEHM
Overweight
Fresenius Medical upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Hassan Al-Wakeel upgraded Fresenius Medical Care to Overweight from Equal Weight and raised his price target for the shares to 81.50 euros from 71 euros. After speaking with CEO Rice Powell and a deep-dive into U.S. dialysis market fundamentals, the analyst believes market concerns around the medium-term sustainability of growth are likely overdone. The analyst has started to see some improvements in the business and believes expectations are now achievable. He now sees a "compelling" risk/reward over the medium term for shares of Fresenius Medical.

TODAY'S FREE FLY STORIES

CTMX

CytomX Therapeutics

$5.17

-0.01 (-0.19%)

16:15
11/19/19
11/19
16:15
11/19/19
16:15
Initiation
CytomX Therapeutics initiated  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$98.02

5.32 (5.74%)

16:14
11/19/19
11/19
16:14
11/19/19
16:14
Initiation
Alnylam initiated  »

Oppenheimer starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 04

    Feb

AKCA

Akcea Therapeutics

$19.06

0.31 (1.65%)

, IONS

Ionis Pharmaceuticals

$58.03

0.26 (0.45%)

16:13
11/19/19
11/19
16:13
11/19/19
16:13
Hot Stocks
Akcea Therapeutics announces closing of licensing agreement with Pfizer »

Akcea Therapeutics…

AKCA

Akcea Therapeutics

$19.06

0.31 (1.65%)

IONS

Ionis Pharmaceuticals

$58.03

0.26 (0.45%)

PFE

Pfizer

$37.64

0.43 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 22

    Nov

  • 07

    Dec

ENDP

Endo

$4.44

-0.02 (-0.45%)

16:11
11/19/19
11/19
16:11
11/19/19
16:11
Hot Stocks
Endo announces FDA accepted for review the original BLA for CCH »

Endo International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNNE

Cannae Holdings

$36.57

-0.27 (-0.73%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Hot Stocks
Cannae Holdings names Richard Massey as new CEO »

Cannae Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$22.72

0.09 (0.40%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Initiation
Amarin initiated  »

Amarin initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

JNJ

Johnson & Johnson

$134.83

-0.01 (-0.01%)

16:10
11/19/19
11/19
16:10
11/19/19
16:10
Initiation
Johnson & Johnson initiated  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 21

    Jan

DAN

Dana

$16.81

0.105 (0.63%)

16:09
11/19/19
11/19
16:09
11/19/19
16:09
Initiation
Dana initiated  »

Dana initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$28.62

-1.54 (-5.11%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Earnings
Urban Outfitters reports Q3 EPS 56c, consensus 57c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

ALNY

Alnylam

$97.88

5.18 (5.59%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Initiation
Alnylam initiated  »

Alnylam initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 04

    Feb

DFFN

Diffusion Pharmaceuticals

$0.22

-0.0013 (-0.58%)

16:08
11/19/19
11/19
16:08
11/19/19
16:08
Hot Stocks
Diffusion Pharmaceuticals announces increased survival in TSC plus SOC trial »

Diffusion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEWM

New Media

$6.33

0.005 (0.08%)

, GCI

Gannett

$9.68

(0.00%)

16:06
11/19/19
11/19
16:06
11/19/19
16:06
Hot Stocks
New Media, Gannett complete merger »

New Media Investment…

NEWM

New Media

$6.33

0.005 (0.08%)

GCI

Gannett

$9.68

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.05

-0.28 (-2.27%)

16:06
11/19/19
11/19
16:06
11/19/19
16:06
Hot Stocks
Avaya names Anthony Bartolo chief product officer »

Avaya Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NYMT

New York Mortgage

$6.25

0.01 (0.16%)

16:05
11/19/19
11/19
16:05
11/19/19
16:05
Syndicate
New York Mortgage files to sell 25M shares of common stock »

Morgan Stanley will serve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRTC

iRhythm

$71.03

1 (1.43%)

16:05
11/19/19
11/19
16:05
11/19/19
16:05
Hot Stocks
iRhythm receives Nasdaq deficiency notice due to delayed quarterly report »

iRhythm Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSEX

Middlesex Water

$61.64

1.07 (1.77%)

16:04
11/19/19
11/19
16:04
11/19/19
16:04
Syndicate
Middlesex Water files to sell $35M in common stock »

Baird is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORGO

Organogenesis

$8.00

0.01 (0.13%)

16:04
11/19/19
11/19
16:04
11/19/19
16:04
Syndicate
Organogenesis files to sell 9M shares of common stock »

Credit Suisse Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAPL

CrossAmerica

$17.35

0.225 (1.31%)

16:03
11/19/19
11/19
16:03
11/19/19
16:03
Hot Stocks
Couche-Tard sells interest in CrossAmerica to investment entities »

Alimentation Couche-Tard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CKPT

Checkpoint Therapeutics

$1.53

-0.08 (-4.97%)

16:03
11/19/19
11/19
16:03
11/19/19
16:03
Syndicate
Checkpoint Therapeutics files to sell common stock, no amount given »

National Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBNC

First Bancorp

$38.66

0.39 (1.02%)

16:03
11/19/19
11/19
16:03
11/19/19
16:03
Hot Stocks
First Bancorp raises dividend 50%, announces $40M share repurchase program »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$22.97

-0.48 (-2.05%)

16:01
11/19/19
11/19
16:01
11/19/19
16:01
Syndicate
Axonics files to sell $110M in common stock »

The offering is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

HD

Home Depot

$226.12

-12.86 (-5.38%)

16:00
11/19/19
11/19
16:00
11/19/19
16:00
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 11

    Dec

CRC

California Resources

$6.39

-2.08 (-24.56%)

, BRY

Berry Petroleum

$8.89

-2.415 (-21.36%)

15:56
11/19/19
11/19
15:56
11/19/19
15:56
Periodicals
California Resources sees no significant impact from CA review, Bloomberg says »

California Resources…

CRC

California Resources

$6.39

-2.08 (-24.56%)

BRY

Berry Petroleum

$8.89

-2.415 (-21.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

15:45
11/19/19
11/19
15:45
11/19/19
15:45
Options
Tandem Diabetes call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$311.99

-0.02 (-0.01%)

15:44
11/19/19
11/19
15:44
11/19/19
15:44
Periodicals
Trump claims Pelosi stalling trade deal amid impeachment inquiry, WSJ says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$311.99

-0.02 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.